Ilsung Is Co., Ltd. (KRX:003120)
South Korea · Delayed Price · Currency is KRW 20,650
0.00 (0.00%)
Last updated: May 15, 2026, 11:56 AM KST
Ilsung Is Market Cap
Ilsung Is has a market cap or net worth of 143.91 billion as of May 14, 2026. Its market cap has increased by 36.12% in one year.
Market Cap
143.91B
Enterprise Value
-81.89B
Revenue
64.29B
Ranking
n/a
PE Ratio
123.44
Stock Price
20,650.00
Market Cap Chart
Since May 22, 1998, Ilsung Is's market cap has increased from 17.63B to 143.91B, an increase of 716.49%. That is a compound annual growth rate of 7.79%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 13, 2026 | 142.52B | -6.19% |
| Dec 30, 2025 | 151.92B | 40.65% |
| Dec 30, 2024 | 108.02B | -34.46% |
| Dec 28, 2023 | 164.82B | 31.69% |
| Dec 29, 2022 | 125.15B | 26.20% |
| Dec 30, 2021 | 99.17B | -10.76% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| JW Lifescience | 189.07B |
| Samil Pharmaceutical Co.,Ltd | 183.64B |
| Ilyang Pharmaceutical Co.,Ltd | 177.46B |
| SAMSUNG PHARM. Co., LTD. | 166.59B |
| Hana Pharm | 164.58B |
| Daihan Pharmaceutical | 162.58B |
| Dongwha Pharm.Co.,Ltd | 161.32B |
| Kyongbo Pharmaceutical | 151.81B |